Sébastien Morin
banner
sebmoringva.bsky.social
Sébastien Morin
@sebmoringva.bsky.social
Senior Manager - Policy, Strategy and Market Access
Medicines Patent Pool (Switzerland)
[ Posting on #GlobalHealth in personal capacity. ]
⭐️ Health is a human right ⭐️
Reposted by Sébastien Morin
On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines.

Learn more: www.who.int/initiatives/...

@pablorojo.bsky.social @sebmoringva.bsky.social
November 20, 2025 at 1:20 PM
It was a pleasure to take part in GAP-f annual members' meeting, reviewing the tremendous #progress of our collaborative network in prioritizing #BetterMeds4Kids in 5 new therapeutic areas during 2025! -> This is what #WorldChildrensDay is about!

#SickleCellDisease #Epilepsy #RSV #Dengue #Malaria
November 20, 2025 at 5:22 PM
Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍
November 20, 2025 at 8:22 AM
Among 100,000 #RSV deaths/year in children, 97% are in #LMICs & half in infants <6 months. Today is #WorldChildrensDay & we are reminded about inequitable diseases disproportionately affecting our young loved ones. Let's work together & create real change! 🤍
#Equity #GlobalHealth #BetterMeds4Kids
November 20, 2025 at 8:05 AM
This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍
-
#BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 1:48 PM
Reposted by Sébastien Morin
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 9:15 AM
Reposted by Sébastien Morin
Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact.

Would you like to explore ways in which we could collaborate?
👉 medicinespatentpool.org/licensingsav...

#FundingHealthEquity #GlobalHealth
November 10, 2025 at 4:24 PM
Reposted by Sébastien Morin
With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth!

#Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs.

#AccessToMedicines #HealthEquity
November 7, 2025 at 4:42 PM
The Global Accelerator for Paediatric Formulations (GAP-f) at
@who.int & @accesstomedicinefoundation.org invite pharmaceutical innovators & manufacturers to discuss the GAP-f 2025-30 strategy & discuss medicines for childhood cancer, epilepsy, malaria, RSV -> Register at who.zoom.us/meeting/regi...
Welcome! You are invited to join a meeting: GAP-f Private Sector Entities Dialogue 2025. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: GAP-f Private Sector Entities Dialogue 2025. After registering, you will receive a confirmation email about joining the meeting.
who.zoom.us
October 22, 2025 at 3:11 PM
Reposted by Sébastien Morin
Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.

Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!

lnkd.in/eruiP-Gv
September 22, 2025 at 1:52 PM
Reposted by Sébastien Morin
Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign.

Thank you to all colleagues for your energy, we look forward to what lies ahead!
September 23, 2025 at 9:41 AM
Reposted by Sébastien Morin
At the UN High-Level Meeting on NCDs and Mental Health, MPP and partners convened a roundtable on expanding access to NCD medicines in LMICs.

Together, we aim to turn commitments into action for equitable, affordable access. 🌍

medicinespatentpool.org/news-publica...
October 3, 2025 at 10:57 AM
Reposted by Sébastien Morin
MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs.

👉 medicinespatentpool.org/story-post/m...
October 6, 2025 at 9:37 AM
Reposted by Sébastien Morin
🌍 We’re hiring!

The Medicines Patent Pool is looking for a Programme Finance Officer to join our team in Geneva, Switzerland.

📅 Apply by: 31 October 2025
📧 Send your application to: recruitment@medicinespatentpool.org

Learn more 👉 medicinespatentpool.org/call-for-app...
October 9, 2025 at 12:35 PM
Reposted by Sébastien Morin
Meaningful days in Accra for #AHMTEC2025!

MPP’s Tiwadayo Braimoh and Meghmala Das joined a panel on #licensing opportunities for African manufacturing, showcasing how the MPP model supports access to essential health products and builds sustainable manufacturing capacity across #Africa.
October 13, 2025 at 11:25 AM
Reposted by Sébastien Morin
💊 The price of generic TLD (tenofovir, lamivudine, dolutegravir), the WHO-recommended HIV treatment, now costs under $37 per person per year, this has been a game changer in low- and middle-income countries.🌏

🤝 How we can collaborate together: medicinespatentpool.org/licensingsav...
October 15, 2025 at 11:54 AM
Reposted by Sébastien Morin
🌍 MPP at #CPHIA2025

MPP is pleased to participate in this year’s #CPHIA2025, joining partners to discuss sustainable #localmanufacturing and equitable access to medical products across Africa.

@eburrone.bsky.social - @tiwabraimoh.bsky.social
October 20, 2025 at 8:20 AM
Reposted by Sébastien Morin
Children are too often left out of clinical trials. In Nature, our Head of HIV Justine Odionyi calls for drug development on neglected diseases to include children from the start. Read the piece (EN/FR): @nature.com #BeatNTDs #GlobalHealth www.nature.com/articles/d44...
Drug development for neglected diseases must account for kids
Including children in trials, shaping regulation locally, could deliver safer, more effective therapies in Africa.
www.nature.com
October 3, 2025 at 8:03 AM
Reposted by Sébastien Morin
Voluntary #LicensingSavesLives by making medicines and health technologies affordable for low- and middle-income countries. 🌍

🤝 But we cannot achieve this great change without your help!

👉 medicinespatentpool.org/licensingsav...
October 1, 2025 at 2:03 PM
Very #proud of being part of the amazing @medicinespatentpool.org #team! Together, we make a positive difference for #GlobalHealth!
Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign.

Thank you to all colleagues for your energy, we look forward to what lies ahead!
September 23, 2025 at 1:53 PM
Ensuring #equity in #access is how we can transform #innovation into positive #health outcomes. Have a look at the short film below and read the latest article from colleagues on "Expanding access to long-acting #HIV therapy in low-income and middle-income countries" 💙
lnkd.in/eTd3TMDM
#GlobalHealth
August 20, 2025 at 3:07 PM
An #timely & #symbolic #milestone for long-acting #HIV #prevention and #treatment ! A privilege to be at #IAS2025 to share positive news with #partners of community, civil society, academia, governments, international organizations, industry...
--
#GlobalHealth #AccessToMedicines #Equity #Solidarity
The MPP and ViiV have expanded their agreement to now include cabotegravir long-acting for both #HIV prevention and treatment.
This is the first fully long-acting HIV treatment made available through a voluntary licence in low- and middle- income countries.

#IAS2025 #ViiV #Unitaid
July 25, 2025 at 7:30 PM
Reposted by Sébastien Morin
Unitaid applauds ViiV Healthcare and the @medicinespatentpool.org for advancing equitable access to HIV treatment. Strong partnerships like this help deliver life-changing innovations to the communities that need them most.

Learn more: medicinespatentpool.org/news-publica...
July 16, 2025 at 7:34 AM
Reposted by Sébastien Morin
“We don’t have to explain ourselves all over again.”

In Kigali, we visited HDI, led by Dr. Aflodis Kagaba, where sex workers, LGBTQ+ people & people who use drugs find stigma-free care, every day.

✍️ Read the full story: medicinespatentpool.org/story-post/b...
July 23, 2025 at 3:34 PM
Reposted by Sébastien Morin
🚨 We’re hiring!
⚖️ Associate Counsel
💉 Consultant: Feasibility & Concept Design Expert

👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c...

#GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring
July 25, 2025 at 10:36 AM